Clinical Trial: Alpha-TEA Plus Trastuzumab in HER2+ Breast Cancer
Researchers are conducting a phase 1 study to test alpha-TEA and trastuzumab in patients with refractory, HER2+ metastatic breast cancer.
Source: cancertherapyadvisor.com
Stay updated with breaking news from Alpha Tocopheryloxyacetic Acid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers are conducting a phase 1 study to test alpha-TEA and trastuzumab in patients with refractory, HER2+ metastatic breast cancer.